Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Clinical data disclosed on gabapentin enacarbil in restless legs syndrome

April 15, 2010

Pfizer presents new 5-HT2C receptor agonists with antiobesity potential

April 15, 2010

Clinical data disclosed on lamotrigine in secondary progressive multiple sclerosis

April 14, 2010

Bazedoxifene shows potential as endometriosis therapy in preclinical study

April 14, 2010

Almirall presents new DHODH inhibitors suitable for clinical development

April 14, 2010

Preliminary data disclosed from long-term safety/efficacy phase III trial of LibiGel in HSDD

April 14, 2010

Vantia discloses dysmenorrhea candidate VA-111913 at ACS meeting

April 13, 2010

Gaucher's disease patients achieve key therapeutic goals with velaglucerase alfa

April 13, 2010

Johnson & Johnson reports new HIF prolyl hydroxylase inhibitors

April 13, 2010

Novartis optimizes lysophospholipid receptor S1P1 agonists

April 13, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...